カテゴリー： 世界, 医療/バイオ, LP Information

世界のモンテルカストナトリウムチュアブル錠剤市場予測 2023年-2029年

【英語タイトル】Global Montelukast Sodium Chewable Tablets Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC06168）・商品コード：LP23DC06168
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：119
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のモンテルカストナトリウムチュアブル錠剤市場」は、過去の販売実績から2022年の世界のモンテルカストナトリウムチュアブル錠剤の総販売量を検討し、2023年から2029年の予測されるモンテルカストナトリウムチュアブル錠剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のモンテルカストナトリウムチュアブル錠剤の市場規模を掲載し、XXX百万米ドル規模の世界のモンテルカストナトリウムチュアブル錠剤市場の詳細な分析を提供します。本インサイトレポートは、世界のモンテルカストナトリウムチュアブル錠剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のモンテルカストナトリウムチュアブル錠剤市場における各社の独自のポジションをより深く理解するために、モンテルカストナトリウムチュアブル錠剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のモンテルカストナトリウムチュアブル錠剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。モンテルカストナトリウムチュアブル錠剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。モンテルカストナトリウムチュアブル錠剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。モンテルカストナトリウムチュアブル錠剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

モンテルカストナトリウムチュアブル錠剤の世界主要メーカーとしては、Organon、 Merck、 Teva Pharmaceuticals、 Sandoz、 Mylan N.V.、 GSK、 Pfizer、 Yangtze River Pharmaceutical (Group) Co., Ltd.、 Beijing Foyou Pharma CO.,Ltd.、 Nanjing Hicin Pharmaceutical Co., Ltd.、 Zhejiang Nuode Pharmaceutical Co., Ltd.、 Hefei Yingtai Pharmaceutical Co., Ltd.、 Lunan Better Pharmaceutical Co., Ltd.、 Sichuan Otsuka Pharmaceutical Co., Ltd.、 Qilu Pharmaceutical (Hainan) Co., Ltd.、 Cspc Ouyi Pharmaceutical Co., Ltd.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のモンテルカストナトリウムチュアブル錠剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではモンテルカストナトリウムチュアブル錠剤市場をセグメンテーションし、種類別 (4mg/錠剤、5mg/錠剤)、用途別 (病院、クリニック、薬局、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：4mg/錠剤、5mg/錠剤

・用途別区分：病院、クリニック、薬局、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のモンテルカストナトリウムチュアブル錠剤市場の10年間の市場状況・展望は？
・世界および地域別に見たモンテルカストナトリウムチュアブル錠剤市場成長の要因は何か？
・モンテルカストナトリウムチュアブル錠剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・モンテルカストナトリウムチュアブル錠剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：モンテルカストナトリウムチュアブル錠剤の年間販売量2018-2029、地域別現状・将来分析
・モンテルカストナトリウムチュアブル錠剤の種類別セグメント：4mg/錠剤、5mg/錠剤
・モンテルカストナトリウムチュアブル錠剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・モンテルカストナトリウムチュアブル錠剤の用途別セグメント：病院、クリニック、薬局、その他
・モンテルカストナトリウムチュアブル錠剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のモンテルカストナトリウムチュアブル錠剤市場
・企業別のグローバルモンテルカストナトリウムチュアブル錠剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別のモンテルカストナトリウムチュアブル錠剤の年間売上：2018-2023年の売上、市場シェア
・企業別のモンテルカストナトリウムチュアブル錠剤販売価格
・主要企業のモンテルカストナトリウムチュアブル錠剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

モンテルカストナトリウムチュアブル錠剤の地域別レビュー
・地域別のモンテルカストナトリウムチュアブル錠剤市場規模2018-2023：年間販売量、売上
・主要国別のモンテルカストナトリウムチュアブル錠剤市場規模2018-2023：年間販売量、売上
・南北アメリカのモンテルカストナトリウムチュアブル錠剤販売の成長
・アジア太平洋のモンテルカストナトリウムチュアブル錠剤販売の成長
・ヨーロッパのモンテルカストナトリウムチュアブル錠剤販売の成長
・中東・アフリカのモンテルカストナトリウムチュアブル錠剤販売の成長

南北アメリカ市場
・南北アメリカの国別のモンテルカストナトリウムチュアブル錠剤販売量、売上（2018-2023）
・南北アメリカのモンテルカストナトリウムチュアブル錠剤の種類別販売量
・南北アメリカのモンテルカストナトリウムチュアブル錠剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のモンテルカストナトリウムチュアブル錠剤販売量、売上（2018-2023）
・アジア太平洋のモンテルカストナトリウムチュアブル錠剤の種類別販売量
・アジア太平洋のモンテルカストナトリウムチュアブル錠剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のモンテルカストナトリウムチュアブル錠剤販売量、売上（2018-2023）
・ヨーロッパのモンテルカストナトリウムチュアブル錠剤の種類別販売量
・ヨーロッパのモンテルカストナトリウムチュアブル錠剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のモンテルカストナトリウムチュアブル錠剤販売量、売上（2018-2023）
・中東・アフリカのモンテルカストナトリウムチュアブル錠剤の種類別販売量
・中東・アフリカのモンテルカストナトリウムチュアブル錠剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・モンテルカストナトリウムチュアブル錠剤の製造コスト構造分析
・モンテルカストナトリウムチュアブル錠剤の製造プロセス分析
・モンテルカストナトリウムチュアブル錠剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・モンテルカストナトリウムチュアブル錠剤の主要なグローバル販売業者
・モンテルカストナトリウムチュアブル錠剤の主要なグローバル顧客

地域別のモンテルカストナトリウムチュアブル錠剤市場予測レビュー
・地域別のモンテルカストナトリウムチュアブル錠剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・モンテルカストナトリウムチュアブル錠剤の種類別市場規模予測
・モンテルカストナトリウムチュアブル錠剤の用途別市場規模予測

主要企業分析
Organon、 Merck、 Teva Pharmaceuticals、 Sandoz、 Mylan N.V.、 GSK、 Pfizer、 Yangtze River Pharmaceutical (Group) Co., Ltd.、 Beijing Foyou Pharma CO.,Ltd.、 Nanjing Hicin Pharmaceutical Co., Ltd.、 Zhejiang Nuode Pharmaceutical Co., Ltd.、 Hefei Yingtai Pharmaceutical Co., Ltd.、 Lunan Better Pharmaceutical Co., Ltd.、 Sichuan Otsuka Pharmaceutical Co., Ltd.、 Qilu Pharmaceutical (Hainan) Co., Ltd.、 Cspc Ouyi Pharmaceutical Co., Ltd.
・企業情報
・モンテルカストナトリウムチュアブル錠剤製品
・モンテルカストナトリウムチュアブル錠剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Montelukast Sodium Chewable Tablets market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Montelukast Sodium Chewable Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Montelukast Sodium Chewable Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Montelukast Sodium Chewable Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Montelukast Sodium Chewable Tablets players cover Organon, Merck, Teva Pharmaceuticals, Sandoz, Mylan N.V., GSK, Pfizer, Yangtze River Pharmaceutical (Group) Co., Ltd. and Beijing Foyou Pharma CO.,Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Montelukast Sodium Chewable Tablets is a selective cysteinyl leukotriene receptor antagonist, mainly used for the prevention and long-term treatment of asthma and to relieve the symptoms of allergic rhinitis, and can also be used for chronic urticaria and children with non-severe diseases such as obstructive sleep apnea.
LPI (LP Information)’ newest research report, the “Montelukast Sodium Chewable Tablets Industry Forecast” looks at past sales and reviews total world Montelukast Sodium Chewable Tablets sales in 2022, providing a comprehensive analysis by region and market sector of projected Montelukast Sodium Chewable Tablets sales for 2023 through 2029. With Montelukast Sodium Chewable Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Montelukast Sodium Chewable Tablets industry.
This Insight Report provides a comprehensive analysis of the global Montelukast Sodium Chewable Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Montelukast Sodium Chewable Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Montelukast Sodium Chewable Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Montelukast Sodium Chewable Tablets and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Montelukast Sodium Chewable Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast Sodium Chewable Tablets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
4mg/tablet
5mg/tablet
Segmentation by application
Hospital
Clinic
Retail Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Organon
Merck
Teva Pharmaceuticals
Sandoz
Mylan N.V.
GSK
Pfizer
Yangtze River Pharmaceutical (Group) Co., Ltd.
Beijing Foyou Pharma CO.,Ltd.
Nanjing Hicin Pharmaceutical Co., Ltd.
Zhejiang Nuode Pharmaceutical Co., Ltd.
Hefei Yingtai Pharmaceutical Co., Ltd.
Lunan Better Pharmaceutical Co., Ltd.
Sichuan Otsuka Pharmaceutical Co., Ltd.
Qilu Pharmaceutical (Hainan) Co., Ltd.
Cspc Ouyi Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Montelukast Sodium Chewable Tablets market?
What factors are driving Montelukast Sodium Chewable Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Montelukast Sodium Chewable Tablets market opportunities vary by end market size?
How does Montelukast Sodium Chewable Tablets break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Montelukast Sodium Chewable Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Montelukast Sodium Chewable Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Montelukast Sodium Chewable Tablets by Country/Region, 2018, 2022 & 2029
2.2 Montelukast Sodium Chewable Tablets Segment by Type
2.2.1 4mg/tablet
2.2.2 5mg/tablet
2.3 Montelukast Sodium Chewable Tablets Sales by Type
2.3.1 Global Montelukast Sodium Chewable Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Montelukast Sodium Chewable Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Montelukast Sodium Chewable Tablets Sale Price by Type (2018-2023)
2.4 Montelukast Sodium Chewable Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Retail Pharmacy
2.4.4 Others
2.5 Montelukast Sodium Chewable Tablets Sales by Application
2.5.1 Global Montelukast Sodium Chewable Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Montelukast Sodium Chewable Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Montelukast Sodium Chewable Tablets Sale Price by Application (2018-2023)
3 Global Montelukast Sodium Chewable Tablets by Company
3.1 Global Montelukast Sodium Chewable Tablets Breakdown Data by Company
3.1.1 Global Montelukast Sodium Chewable Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Montelukast Sodium Chewable Tablets Sales Market Share by Company (2018-2023)
3.2 Global Montelukast Sodium Chewable Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Montelukast Sodium Chewable Tablets Revenue by Company (2018-2023)
3.2.2 Global Montelukast Sodium Chewable Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Montelukast Sodium Chewable Tablets Sale Price by Company
3.4 Key Manufacturers Montelukast Sodium Chewable Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Montelukast Sodium Chewable Tablets Product Location Distribution
3.4.2 Players Montelukast Sodium Chewable Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Montelukast Sodium Chewable Tablets by Geographic Region
4.1 World Historic Montelukast Sodium Chewable Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Montelukast Sodium Chewable Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Montelukast Sodium Chewable Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Montelukast Sodium Chewable Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Montelukast Sodium Chewable Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Montelukast Sodium Chewable Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Montelukast Sodium Chewable Tablets Sales Growth
4.4 APAC Montelukast Sodium Chewable Tablets Sales Growth
4.5 Europe Montelukast Sodium Chewable Tablets Sales Growth
4.6 Middle East & Africa Montelukast Sodium Chewable Tablets Sales Growth
5 Americas
5.1 Americas Montelukast Sodium Chewable Tablets Sales by Country
5.1.1 Americas Montelukast Sodium Chewable Tablets Sales by Country (2018-2023)
5.1.2 Americas Montelukast Sodium Chewable Tablets Revenue by Country (2018-2023)
5.2 Americas Montelukast Sodium Chewable Tablets Sales by Type
5.3 Americas Montelukast Sodium Chewable Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Montelukast Sodium Chewable Tablets Sales by Region
6.1.1 APAC Montelukast Sodium Chewable Tablets Sales by Region (2018-2023)
6.1.2 APAC Montelukast Sodium Chewable Tablets Revenue by Region (2018-2023)
6.2 APAC Montelukast Sodium Chewable Tablets Sales by Type
6.3 APAC Montelukast Sodium Chewable Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Montelukast Sodium Chewable Tablets by Country
7.1.1 Europe Montelukast Sodium Chewable Tablets Sales by Country (2018-2023)
7.1.2 Europe Montelukast Sodium Chewable Tablets Revenue by Country (2018-2023)
7.2 Europe Montelukast Sodium Chewable Tablets Sales by Type
7.3 Europe Montelukast Sodium Chewable Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Montelukast Sodium Chewable Tablets by Country
8.1.1 Middle East & Africa Montelukast Sodium Chewable Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Montelukast Sodium Chewable Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Montelukast Sodium Chewable Tablets Sales by Type
8.3 Middle East & Africa Montelukast Sodium Chewable Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Montelukast Sodium Chewable Tablets
10.3 Manufacturing Process Analysis of Montelukast Sodium Chewable Tablets
10.4 Industry Chain Structure of Montelukast Sodium Chewable Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Montelukast Sodium Chewable Tablets Distributors
11.3 Montelukast Sodium Chewable Tablets Customer
12 World Forecast Review for Montelukast Sodium Chewable Tablets by Geographic Region
12.1 Global Montelukast Sodium Chewable Tablets Market Size Forecast by Region
12.1.1 Global Montelukast Sodium Chewable Tablets Forecast by Region (2024-2029)
12.1.2 Global Montelukast Sodium Chewable Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Montelukast Sodium Chewable Tablets Forecast by Type
12.7 Global Montelukast Sodium Chewable Tablets Forecast by Application
13 Key Players Analysis
13.1 Organon
13.1.1 Organon Company Information
13.1.2 Organon Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.1.3 Organon Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Organon Main Business Overview
13.1.5 Organon Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.2.3 Merck Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Teva Pharmaceuticals
13.3.1 Teva Pharmaceuticals Company Information
13.3.2 Teva Pharmaceuticals Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.3.3 Teva Pharmaceuticals Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Pharmaceuticals Main Business Overview
13.3.5 Teva Pharmaceuticals Latest Developments
13.4 Sandoz
13.4.1 Sandoz Company Information
13.4.2 Sandoz Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.4.3 Sandoz Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sandoz Main Business Overview
13.4.5 Sandoz Latest Developments
13.5 Mylan N.V.
13.5.1 Mylan N.V. Company Information
13.5.2 Mylan N.V. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.5.3 Mylan N.V. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan N.V. Main Business Overview
13.5.5 Mylan N.V. Latest Developments
13.6 GSK
13.6.1 GSK Company Information
13.6.2 GSK Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.6.3 GSK Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GSK Main Business Overview
13.6.5 GSK Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.7.3 Pfizer Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Yangtze River Pharmaceutical (Group) Co., Ltd.
13.8.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
13.8.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.8.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.8.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
13.9 Beijing Foyou Pharma CO.,Ltd.
13.9.1 Beijing Foyou Pharma CO.,Ltd. Company Information
13.9.2 Beijing Foyou Pharma CO.,Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.9.3 Beijing Foyou Pharma CO.,Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Beijing Foyou Pharma CO.,Ltd. Main Business Overview
13.9.5 Beijing Foyou Pharma CO.,Ltd. Latest Developments
13.10 Nanjing Hicin Pharmaceutical Co., Ltd.
13.10.1 Nanjing Hicin Pharmaceutical Co., Ltd. Company Information
13.10.2 Nanjing Hicin Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.10.3 Nanjing Hicin Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nanjing Hicin Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Nanjing Hicin Pharmaceutical Co., Ltd. Latest Developments
13.11 Zhejiang Nuode Pharmaceutical Co., Ltd.
13.11.1 Zhejiang Nuode Pharmaceutical Co., Ltd. Company Information
13.11.2 Zhejiang Nuode Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.11.3 Zhejiang Nuode Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Zhejiang Nuode Pharmaceutical Co., Ltd. Main Business Overview
13.11.5 Zhejiang Nuode Pharmaceutical Co., Ltd. Latest Developments
13.12 Hefei Yingtai Pharmaceutical Co., Ltd.
13.12.1 Hefei Yingtai Pharmaceutical Co., Ltd. Company Information
13.12.2 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.12.3 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hefei Yingtai Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Hefei Yingtai Pharmaceutical Co., Ltd. Latest Developments
13.13 Lunan Better Pharmaceutical Co., Ltd.
13.13.1 Lunan Better Pharmaceutical Co., Ltd. Company Information
13.13.2 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.13.3 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Lunan Better Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Lunan Better Pharmaceutical Co., Ltd. Latest Developments
13.14 Sichuan Otsuka Pharmaceutical Co., Ltd.
13.14.1 Sichuan Otsuka Pharmaceutical Co., Ltd. Company Information
13.14.2 Sichuan Otsuka Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.14.3 Sichuan Otsuka Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sichuan Otsuka Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Sichuan Otsuka Pharmaceutical Co., Ltd. Latest Developments
13.15 Qilu Pharmaceutical (Hainan) Co., Ltd.
13.15.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Company Information
13.15.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.15.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Main Business Overview
13.15.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Latest Developments
13.16 Cspc Ouyi Pharmaceutical Co., Ltd.
13.16.1 Cspc Ouyi Pharmaceutical Co., Ltd. Company Information
13.16.2 Cspc Ouyi Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.16.3 Cspc Ouyi Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Cspc Ouyi Pharmaceutical Co., Ltd. Main Business Overview
13.16.5 Cspc Ouyi Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Montelukast Sodium Chewable Tablets Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Montelukast Sodium Chewable Tablets Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 4mg/tablet
Table 4. Major Players of 5mg/tablet
Table 5. Global Montelukast Sodium Chewable Tablets Sales by Type (2018-2023) & (K Units)
Table 6. Global Montelukast Sodium Chewable Tablets Sales Market Share by Type (2018-2023)
Table 7. Global Montelukast Sodium Chewable Tablets Revenue by Type (2018-2023) & ($ million)
Table 8. Global Montelukast Sodium Chewable Tablets Revenue Market Share by Type (2018-2023)
Table 9. Global Montelukast Sodium Chewable Tablets Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Montelukast Sodium Chewable Tablets Sales by Application (2018-2023) & (K Units)
Table 11. Global Montelukast Sodium Chewable Tablets Sales Market Share by Application (2018-2023)
Table 12. Global Montelukast Sodium Chewable Tablets Revenue by Application (2018-2023)
Table 13. Global Montelukast Sodium Chewable Tablets Revenue Market Share by Application (2018-2023)
Table 14. Global Montelukast Sodium Chewable Tablets Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Montelukast Sodium Chewable Tablets Sales by Company (2018-2023) & (K Units)
Table 16. Global Montelukast Sodium Chewable Tablets Sales Market Share by Company (2018-2023)
Table 17. Global Montelukast Sodium Chewable Tablets Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Montelukast Sodium Chewable Tablets Revenue Market Share by Company (2018-2023)
Table 19. Global Montelukast Sodium Chewable Tablets Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Montelukast Sodium Chewable Tablets Producing Area Distribution and Sales Area
Table 21. Players Montelukast Sodium Chewable Tablets Products Offered
Table 22. Montelukast Sodium Chewable Tablets Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Montelukast Sodium Chewable Tablets Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Montelukast Sodium Chewable Tablets Sales Market Share Geographic Region (2018-2023)
Table 27. Global Montelukast Sodium Chewable Tablets Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Montelukast Sodium Chewable Tablets Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Montelukast Sodium Chewable Tablets Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Montelukast Sodium Chewable Tablets Sales Market Share by Country/Region (2018-2023)
Table 31. Global Montelukast Sodium Chewable Tablets Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Montelukast Sodium Chewable Tablets Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Montelukast Sodium Chewable Tablets Sales by Country (2018-2023) & (K Units)
Table 34. Americas Montelukast Sodium Chewable Tablets Sales Market Share by Country (2018-2023)
Table 35. Americas Montelukast Sodium Chewable Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Montelukast Sodium Chewable Tablets Revenue Market Share by Country (2018-2023)
Table 37. Americas Montelukast Sodium Chewable Tablets Sales by Type (2018-2023) & (K Units)
Table 38. Americas Montelukast Sodium Chewable Tablets Sales by Application (2018-2023) & (K Units)
Table 39. APAC Montelukast Sodium Chewable Tablets Sales by Region (2018-2023) & (K Units)
Table 40. APAC Montelukast Sodium Chewable Tablets Sales Market Share by Region (2018-2023)
Table 41. APAC Montelukast Sodium Chewable Tablets Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Montelukast Sodium Chewable Tablets Revenue Market Share by Region (2018-2023)
Table 43. APAC Montelukast Sodium Chewable Tablets Sales by Type (2018-2023) & (K Units)
Table 44. APAC Montelukast Sodium Chewable Tablets Sales by Application (2018-2023) & (K Units)
Table 45. Europe Montelukast Sodium Chewable Tablets Sales by Country (2018-2023) & (K Units)
Table 46. Europe Montelukast Sodium Chewable Tablets Sales Market Share by Country (2018-2023)
Table 47. Europe Montelukast Sodium Chewable Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Montelukast Sodium Chewable Tablets Revenue Market Share by Country (2018-2023)
Table 49. Europe Montelukast Sodium Chewable Tablets Sales by Type (2018-2023) & (K Units)
Table 50. Europe Montelukast Sodium Chewable Tablets Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Montelukast Sodium Chewable Tablets Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Montelukast Sodium Chewable Tablets Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Montelukast Sodium Chewable Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Montelukast Sodium Chewable Tablets Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Montelukast Sodium Chewable Tablets Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Montelukast Sodium Chewable Tablets Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Montelukast Sodium Chewable Tablets
Table 58. Key Market Challenges & Risks of Montelukast Sodium Chewable Tablets
Table 59. Key Industry Trends of Montelukast Sodium Chewable Tablets
Table 60. Montelukast Sodium Chewable Tablets Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Montelukast Sodium Chewable Tablets Distributors List
Table 63. Montelukast Sodium Chewable Tablets Customer List
Table 64. Global Montelukast Sodium Chewable Tablets Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Montelukast Sodium Chewable Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Montelukast Sodium Chewable Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Montelukast Sodium Chewable Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Montelukast Sodium Chewable Tablets Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Montelukast Sodium Chewable Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Montelukast Sodium Chewable Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Montelukast Sodium Chewable Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Montelukast Sodium Chewable Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Montelukast Sodium Chewable Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Montelukast Sodium Chewable Tablets Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Montelukast Sodium Chewable Tablets Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Montelukast Sodium Chewable Tablets Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Montelukast Sodium Chewable Tablets Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Organon Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 79. Organon Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 80. Organon Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Organon Main Business
Table 82. Organon Latest Developments
Table 83. Merck Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 85. Merck Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Teva Pharmaceuticals Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Pharmaceuticals Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 90. Teva Pharmaceuticals Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Teva Pharmaceuticals Main Business
Table 92. Teva Pharmaceuticals Latest Developments
Table 93. Sandoz Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 94. Sandoz Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 95. Sandoz Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Sandoz Main Business
Table 97. Sandoz Latest Developments
Table 98. Mylan N.V. Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Mylan N.V. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 100. Mylan N.V. Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Mylan N.V. Main Business
Table 102. Mylan N.V. Latest Developments
Table 103. GSK Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 104. GSK Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 105. GSK Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. GSK Main Business
Table 107. GSK Latest Developments
Table 108. Pfizer Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 109. Pfizer Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 110. Pfizer Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Pfizer Main Business
Table 112. Pfizer Latest Developments
Table 113. Yangtze River Pharmaceutical (Group) Co., Ltd. Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 114. Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 115. Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business
Table 117. Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
Table 118. Beijing Foyou Pharma CO.,Ltd. Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 119. Beijing Foyou Pharma CO.,Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 120. Beijing Foyou Pharma CO.,Ltd. Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Beijing Foyou Pharma CO.,Ltd. Main Business
Table 122. Beijing Foyou Pharma CO.,Ltd. Latest Developments
Table 123. Nanjing Hicin Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 124. Nanjing Hicin Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 125. Nanjing Hicin Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Nanjing Hicin Pharmaceutical Co., Ltd. Main Business
Table 127. Nanjing Hicin Pharmaceutical Co., Ltd. Latest Developments
Table 128. Zhejiang Nuode Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 129. Zhejiang Nuode Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 130. Zhejiang Nuode Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Zhejiang Nuode Pharmaceutical Co., Ltd. Main Business
Table 132. Zhejiang Nuode Pharmaceutical Co., Ltd. Latest Developments
Table 133. Hefei Yingtai Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 134. Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 135. Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Hefei Yingtai Pharmaceutical Co., Ltd. Main Business
Table 137. Hefei Yingtai Pharmaceutical Co., Ltd. Latest Developments
Table 138. Lunan Better Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 139. Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 140. Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Lunan Better Pharmaceutical Co., Ltd. Main Business
Table 142. Lunan Better Pharmaceutical Co., Ltd. Latest Developments
Table 143. Sichuan Otsuka Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 144. Sichuan Otsuka Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 145. Sichuan Otsuka Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Sichuan Otsuka Pharmaceutical Co., Ltd. Main Business
Table 147. Sichuan Otsuka Pharmaceutical Co., Ltd. Latest Developments
Table 148. Qilu Pharmaceutical (Hainan) Co., Ltd. Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 149. Qilu Pharmaceutical (Hainan) Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 150. Qilu Pharmaceutical (Hainan) Co., Ltd. Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Qilu Pharmaceutical (Hainan) Co., Ltd. Main Business
Table 152. Qilu Pharmaceutical (Hainan) Co., Ltd. Latest Developments
Table 153. Cspc Ouyi Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 154. Cspc Ouyi Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
Table 155. Cspc Ouyi Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Cspc Ouyi Pharmaceutical Co., Ltd. Main Business
Table 157. Cspc Ouyi Pharmaceutical Co., Ltd. Latest Developments
List of Figures
Figure 1. Picture of Montelukast Sodium Chewable Tablets
Figure 2. Montelukast Sodium Chewable Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Montelukast Sodium Chewable Tablets Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Montelukast Sodium Chewable Tablets Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Montelukast Sodium Chewable Tablets Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 4mg/tablet
Figure 10. Product Picture of 5mg/tablet
Figure 11. Global Montelukast Sodium Chewable Tablets Sales Market Share by Type in 2022
Figure 12. Global Montelukast Sodium Chewable Tablets Revenue Market Share by Type (2018-2023)
Figure 13. Montelukast Sodium Chewable Tablets Consumed in Hospital
Figure 14. Global Montelukast Sodium Chewable Tablets Market: Hospital (2018-2023) & (K Units)
Figure 15. Montelukast Sodium Chewable Tablets Consumed in Clinic
Figure 16. Global Montelukast Sodium Chewable Tablets Market: Clinic (2018-2023) & (K Units)
Figure 17. Montelukast Sodium Chewable Tablets Consumed in Retail Pharmacy
Figure 18. Global Montelukast Sodium Chewable Tablets Market: Retail Pharmacy (2018-2023) & (K Units)
Figure 19. Montelukast Sodium Chewable Tablets Consumed in Others
Figure 20. Global Montelukast Sodium Chewable Tablets Market: Others (2018-2023) & (K Units)
Figure 21. Global Montelukast Sodium Chewable Tablets Sales Market Share by Application (2022)
Figure 22. Global Montelukast Sodium Chewable Tablets Revenue Market Share by Application in 2022
Figure 23. Montelukast Sodium Chewable Tablets Sales Market by Company in 2022 (K Units)
Figure 24. Global Montelukast Sodium Chewable Tablets Sales Market Share by Company in 2022
Figure 25. Montelukast Sodium Chewable Tablets Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Montelukast Sodium Chewable Tablets Revenue Market Share by Company in 2022
Figure 27. Global Montelukast Sodium Chewable Tablets Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Montelukast Sodium Chewable Tablets Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Montelukast Sodium Chewable Tablets Sales 2018-2023 (K Units)
Figure 30. Americas Montelukast Sodium Chewable Tablets Revenue 2018-2023 ($ Millions)
Figure 31. APAC Montelukast Sodium Chewable Tablets Sales 2018-2023 (K Units)
Figure 32. APAC Montelukast Sodium Chewable Tablets Revenue 2018-2023 ($ Millions)
Figure 33. Europe Montelukast Sodium Chewable Tablets Sales 2018-2023 (K Units)
Figure 34. Europe Montelukast Sodium Chewable Tablets Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Montelukast Sodium Chewable Tablets Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Montelukast Sodium Chewable Tablets Revenue 2018-2023 ($ Millions)
Figure 37. Americas Montelukast Sodium Chewable Tablets Sales Market Share by Country in 2022
Figure 38. Americas Montelukast Sodium Chewable Tablets Revenue Market Share by Country in 2022
Figure 39. Americas Montelukast Sodium Chewable Tablets Sales Market Share by Type (2018-2023)
Figure 40. Americas Montelukast Sodium Chewable Tablets Sales Market Share by Application (2018-2023)
Figure 41. United States Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Montelukast Sodium Chewable Tablets Sales Market Share by Region in 2022
Figure 46. APAC Montelukast Sodium Chewable Tablets Revenue Market Share by Regions in 2022
Figure 47. APAC Montelukast Sodium Chewable Tablets Sales Market Share by Type (2018-2023)
Figure 48. APAC Montelukast Sodium Chewable Tablets Sales Market Share by Application (2018-2023)
Figure 49. China Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Montelukast Sodium Chewable Tablets Sales Market Share by Country in 2022
Figure 57. Europe Montelukast Sodium Chewable Tablets Revenue Market Share by Country in 2022
Figure 58. Europe Montelukast Sodium Chewable Tablets Sales Market Share by Type (2018-2023)
Figure 59. Europe Montelukast Sodium Chewable Tablets Sales Market Share by Application (2018-2023)
Figure 60. Germany Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Montelukast Sodium Chewable Tablets Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Montelukast Sodium Chewable Tablets Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Montelukast Sodium Chewable Tablets Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Montelukast Sodium Chewable Tablets Sales Market Share by Application (2018-2023)
Figure 69. Egypt Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Montelukast Sodium Chewable Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Montelukast Sodium Chewable Tablets in 2022
Figure 75. Manufacturing Process Analysis of Montelukast Sodium Chewable Tablets
Figure 76. Industry Chain Structure of Montelukast Sodium Chewable Tablets
Figure 77. Channels of Distribution
Figure 78. Global Montelukast Sodium Chewable Tablets Sales Market Forecast by Region (2024-2029)
Figure 79. Global Montelukast Sodium Chewable Tablets Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Montelukast Sodium Chewable Tablets Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Montelukast Sodium Chewable Tablets Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Montelukast Sodium Chewable Tablets Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Montelukast Sodium Chewable Tablets Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のモンテルカストナトリウムチュアブル錠剤市場予測 2023年-2029年] (コード：LP23DC06168)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のモンテルカストナトリウムチュアブル錠剤市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のメチルプレドニゾロン錠市場予測 2023年-2029年
  • 世界のベンダゾール錠市場予測 2023年-2029年
  • 世界のジメルカプトプロパンスルホン酸ナトリウム注射液市場予測 2023年-2029年
  • 世界のバルプロ酸ナトリウム調製市場予測 2023年-2029年
  • 世界のリトナビル錠剤市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆